These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 2676939

  • 1. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J.
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [Abstract] [Full Text] [Related]

  • 2. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P, Soussy CJ, Orsoni A, Brickley X, Duval J.
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [Abstract] [Full Text] [Related]

  • 3. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
    Philippon A, Jarlier V, Legrand P, Fournier G, Nicolas MH, Duval J.
    Presse Med; 1989 Oct 11; 18(32):1560-6. PubMed ID: 2530532
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug 11; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 5. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
    Mushtaq S, Ge Y, Livermore DM.
    Antimicrob Agents Chemother; 2004 Apr 11; 48(4):1313-9. PubMed ID: 15047535
    [Abstract] [Full Text] [Related]

  • 6. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Apr 11; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 7. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA, Hare R, Papa E, Adam C, Miller GH.
    J Antimicrob Chemother; 1985 Jun 11; 15 Suppl C():119-32. PubMed ID: 3875602
    [Abstract] [Full Text] [Related]

  • 8. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.
    Thomson KS, Sanders CC, Moland ES.
    Antimicrob Agents Chemother; 1999 Jun 11; 43(6):1393-400. PubMed ID: 10348759
    [Abstract] [Full Text] [Related]

  • 9. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V, Nicolas MH, Fournier G, Philippon A.
    Rev Infect Dis; 1988 Jun 11; 10(4):867-78. PubMed ID: 3263690
    [Abstract] [Full Text] [Related]

  • 10. Extended spectrum beta lactamase production & multidrug resistance in Klebsiella species isolated from children under five with intestinal & extraintestinal infections.
    Subha A, Ananthan S, Alavandi SV.
    Indian J Med Res; 2001 May 11; 113():181-5. PubMed ID: 11968952
    [Abstract] [Full Text] [Related]

  • 11. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
    Gutmann L, Kitzis MD, Acar JF.
    J Antimicrob Chemother; 1985 Jun 11; 15 Suppl C():147-54. PubMed ID: 3897168
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC.
    Int J Antimicrob Agents; 2004 Dec 11; 24(6):585-91. PubMed ID: 15555882
    [Abstract] [Full Text] [Related]

  • 13. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A, Baumert P, Hamprecht A, Rohde AM, Peter S, Feihl S, Knobloch J, Gölz H, Kola A, Obermann B, Querbach C, Willmann M, Gebhardt F, Tacconelli E, Gastmeier P, Seifert H, Kern WV, DZIF-ATHOS Study Group.
    J Antimicrob Chemother; 2017 May 01; 72(5):1359-1363. PubMed ID: 28108677
    [Abstract] [Full Text] [Related]

  • 14. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
    Babini GS, Yuan M, Livermore DM.
    Antimicrob Agents Chemother; 1998 May 01; 42(5):1168-75. PubMed ID: 9593145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.
    Bert F, Bialek-Davenet S, Leflon-Guibout V, Noussair L, Nicolas-Chanoine MH.
    Med Mal Infect; 2014 Feb 01; 44(2):76-8. PubMed ID: 24525113
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Development of Beta-lactamase resistance in enterobacteria].
    Koren J, Vaculíková A.
    Klin Mikrobiol Infekc Lek; 2006 Jun 01; 12(3):103-7. PubMed ID: 17051471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.